Did you know that 10 to 15 percent of all pancreatic cancer cases are due to genetics? This is why Dr. Nadeem Hussain, Middlesex Health’s chief of gastroenterology, says it is so important to know your risk.
Middlesex Health offers pancreatic cancer screenings to those who have a reasonable risk of pancreatic cancer based on their personal and family histories. In general, screenings often begin between ages 45 and 50, or 10 to 15 years younger than the youngest relative with pancreatic cancer.
Screenings include a contrast-enhanced MRI and possibly a secretin stimulation test. During a secretin stimulation test, a hormone is given to increase the secretion of juices within the pancreatic gland and enhance imaging. Together, these tools allow doctors to get detailed and reliable views of the pancreas.
An endoscopic ultrasound can also be used to evaluate the pancreatic gland. This procedure involves passing an endoscope through the esophagus into the stomach and small intestine to visualize the pancreas and possibly obtain samples of fluid. It can complement the MRI and increase the odds of discovering and diagnosing lesions early.
Pancreatic cancer is the fourth leading cause of cancer-related death in both males and females, and the average age at the time of diagnosis is 60. Symptoms of pancreatic cancer include:
Lack of appetite
Upper abdominal pain
New onset of diabetes at a late age
Elevated liver enzymes
If you are diagnosed with pancreatic cancer, treatment can vary and can include surgery, chemotherapy and/or radiation therapy. At the Middlesex Health Cancer Center, Dr. Chia-Chi Wang, a fellowship trained surgical oncologist, works in collaboration with gastroenterologists, geneticists, medical oncologists and radiation oncologists and is committed to providing the best care. In addition to performing more traditional surgery, Dr. Wang also performs robotic surgery, a minimally invasive procedure that results in smaller incisions, meaning less discomfort, less scarring and a faster recovery.